Nov 08, 2023
PolyPid Provides Corporate Update and Reports Third Quarter 2023 Financial Results
Nov 07, 2023
PolyPid Announces the Addition of Dr. Nurit Tweezer-Zaks to its Board of Directors
Nov 01, 2023
PolyPid to Report Third Quarter 2023 Financial Results and Operational Highlights on November 8, 2023
Oct 11, 2023
PolyPid Regains Compliance with Nasdaq Minimum Closing Bid Price Rule
Oct 09, 2023
PolyPid Announces Presentation at the American College of Surgeons Clinical Congress 2023
Oct 04, 2023
PolyPid Announces Publication of Preclinical Data Further Supporting the Good Safety Profile of D-PLEX₁₀₀ and PLEX Technology Platform
Sep 22, 2023
PolyPid to Present at the 2023 Cantor Fitzgerald Global Healthcare Conference
Sep 21, 2023
PolyPid Announces Successful Commercial Good Manufacturing Practice (GMP) Audit by Israeli Ministry of Health
Sep 20, 2023
PolyPid Announces Reverse Share Split
Sep 19, 2023
PolyPid Announces Successful Completion of Manufacturing Process Validation for D-PLEX₁₀₀
Displaying 1 - 10 of 28